CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma

Abstract Introduction Diffuse Pleural Mesothelioma (DPM) is a rare and incurable cancer. Immune checkpoint inhibitors (ICIs) marked some advances but only for a limited fraction of patients. Improving response prediction to ICIs is currently a clinical need in DPM. Deletion of CDKN2A gene, in chr9p2...

Full description

Bibliographic Details
Published in:	Journal of Experimental & Clinical Cancer Research
Main Authors:	Federica Torricelli, Benedetta Donati, Veronica Manicardi, Mila Gugnoni, Francesca Reggiani, Gloria Manzotti, Pierluigi Di Chiaro, Cristian Ascione, Simonetta Piana, Riccardo Valli, Roberto Piro, Massimiliano Paci, Nicola Facciolongo, Filippo Lococo, Alessia Ciarrocchi
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Diffuse pleural mesothelioma Tumor immune microenvironment Genetic alteration CDKN2A Immunotherapy
Online Access:	https://doi.org/10.1186/s13046-025-03522-4

Similar Items

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
by: F Torricelli, et al.
Published: (2023-07-01)

Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma
by: Miho Yoshida, et al.
Published: (2023-11-01)

Pleural mesothelioma metastasis of the scalp
by: Tugcem Bicak, et al.
Published: (2024-02-01)

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
by: Giulia Pinton, et al.
Published: (2021-07-01)

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
by: Giulia Pinton, et al.
Published: (2022-11-01)

Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study
by: Federica Pezzuto, et al.
Published: (2020-06-01)

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
by: Sophie Sneddon, et al.
Published: (2017-06-01)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)

Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients
by: Nattaradee Kiatprungvech, et al.
Published: (2024-05-01)

Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN
by: Emanuele Vitale, et al.
Published: (2024-09-01)

Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis
by: Veronica Manicardi, et al.
Published: (2023-12-01)

The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes
by: Federica Torricelli, et al.
Published: (2025-02-01)

Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review
by: Francesca Bono, et al.
Published: (2022-02-01)

Pleural Mesothelioma: Unexpected Finding in a Young Man
by: Raza Ullah, et al.
Published: (2022-07-01)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)

Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)

Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
by: Anita Sejben, et al.
Published: (2023-04-01)

The role of CD24 as a potential biomarker for malignant pleural mesothelioma
by: Mohamed Shaaban Mousa, et al.
Published: (2023-01-01)

Malignant Mesothelioma in Cappadocia: Data from Eight Regional Hospitals
by: İpek Pınar Aral, et al.
Published: (2020-09-01)

Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
by: Margaret Stalker, MD, et al.
Published: (2025-05-01)

Malignant pleural mesothelioma in a child
by: Jed Brendan Scharf, et al.
Published: (2015-10-01)

Malignant mediastinal mesothelioma treated with anlotinib: a case report and review of the literature
by: Yishi Zhang, et al.
Published: (2023-05-01)

Miliary Mesothelioma
by: Dujinthan Jayabalan, et al.
Published: (2025-03-01)

Recurrent malignant peritoneal mesothelioma treated by a second resection: A case report
by: Takashi Miyata, et al.
Published: (2023-05-01)

A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia
by: Xiaoshan Hu, et al.
Published: (2024-12-01)

New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications
by: Maria Giovanna Mastromarino, et al.
Published: (2022-11-01)

Gluteal muscle metastases from malignant pleural mesothelioma: a case report
by: Emanuele Stirpe, et al.
Published: (2024-05-01)

Mesothelioma - a growing medical problem with heterogeneous course
by: Robert Chudzik, et al.
Published: (2019-02-01)

Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis
by: Nanamika Thakur, et al.
Published: (2021-01-01)

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands
by: Illaa Smesseim, et al.
Published: (2025-07-01)

MAF1 represses CDKN1A through a Pol III-dependent mechanism
by: Yu-Ling Lee, et al.
Published: (2015-06-01)

Primary adrenocortical carcinoma with mutation in the CDKN2A gene
by: Changming Dong, et al.
Published: (2023-09-01)

Benign fibrous mesothelioma - a case reportc
by: S Vinod, et al.
Published: (2006-08-01)

<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer Syndromes
by: Anastasiia Danishevich, et al.
Published: (2023-12-01)

Malignant mesothelioma of the peritoneum mimicking primary peritonitis carcinomatosis
by: Saliha Sağnıç, et al.
Published: (2023-12-01)

Antiangiogeneic Strategies in Mesothelioma
by: Anna K. Nowak, et al.
Published: (2020-02-01)

<i>CDKN2A/B</i> Homozygous Deletions in Astrocytomas: A Literature Review
by: Alexander Yuile, et al.
Published: (2023-06-01)

The role of immunohistochemical evaluation in the diagnosis of malignant mesothelioma of the pleura
by: Panjković Milana, et al.
Published: (2013-01-01)

Experiences of Physical Activity in Mesothelioma: A Qualitative Enquiry
by: Lorelle Dismore, et al.
Published: (2024-10-01)